2,3-bis(3-hydroxyphenyl)-6-quinoxalinecarboxylic acid | 90833-57-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2,3-bis(3-hydroxyphenyl)-6-quinoxalinecarboxylic acid
• 英文别名: 2,3-di(3-hydroxyphenyl)quinoxaline-6-carboxylic acid；2,3-bis(3-hydroxyphenyl)quinoxaline-6-carboxylic acid
• CAS: 90833-57-1
• 化学式: C₂₁H₁₄N₂O₄
• 分子量: 358.353
• InChiKey: UKKBZXDYLWHXLI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  104
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  2,3-bis(3-methoxyphenyl)-6-quinoxalinecarboxylic acid 在 乙硫醇钠 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 以79%的产率得到2,3-bis(3-hydroxyphenyl)-6-quinoxalinecarboxylic acid
  参考文献：
  名称：

  Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors

  摘要：

  A library of quinoxaline derivatives were prepared to target non-structural protein 1 of influenza A (NS1A) as a means to develop anti-influenza drug leads. An in vitro fluorescence polarization assay demonstrated that these compounds disrupted the dsRNA-NS1A interaction to varying extents. Changes of substituent at positions 2, 3 and 6 on the quinoxaline ring led to variance in responses. The most active compounds (35 and 44) had IC50 values in the range of low micromolar concentration without exhibiting significant dsRNA intercalation. Compound 44 was able to inhibit influenza A/Udorn/72 virus growth. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.03.042

文献信息

• HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
  申请人：McCall John M.

  公开号：US20140128392A1

  公开（公告）日：2014-05-08

  Disclosed herein are new heterocyclic compounds of Formula IIa: and compositions thereof, and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

  本文披露了新的Formula IIa的杂环化合物及其组合物，以及它们作为治疗疾病的药物的应用。还提供了在人类或动物主体中抑制PAS激酶（PASK）活性的方法，用于治疗糖尿病等疾病。
• Substituted 5- and 6-quinoxalinecarboxylic acids and their tuberculostatic activity
  作者：František Roubínek、Viktor Bydžovský、Zdeněk Buděšínský

  DOI：10.1135/cccc19840285

  日期：——

  Condensation of aliphatic and aliphatic-aromatic α-diketones, and of substituted benzils with 2,3- and 3,4-diaminobenzoic acids and with 4,5-diamino-2-hydroxybenzoic acid gave 74 5- and 6-quinoxalinecarboxylic acids, with the same or different alkyls and aryls as substituents at position 2 and 3. The compounds with different substituents at positions 2 and 3 were resolved into positional isomers. Their structures were determined by means of the dipole moments. The compounds were tested for tuberculostatic activity. Some exhibited it in vitro (LI, LVII), but failed in vivo.

  脂肪族和脂肪族-芳香族α-二酮与2,3-和3,4-二氨基苯甲酸以及4,5-二氨基-2-羟基苯甲酸的缩合反应产生了74种5-和6-喹啉羧酸，位置2和3上的取代基可以是相同的或不同的烷基和芳基。在位置2和3有不同取代基的化合物被分解成位置异构体。它们的结构是通过偶极矩确定的。这些化合物被检测其抗结核活性。一些化合物在体外（LI，LVII）表现出该活性，但在体内失败。
• ROUBINEK, F.;BYDZOVSKY, V.;BUDESINSKY, Z., COLLECT. CZECHOSL. CHEM. COMMUN., 1984, 49, N 1, 285-294
  作者：ROUBINEK, F.、BYDZOVSKY, V.、BUDESINSKY, Z.

  DOI：——

  日期：——
• US9370522B2
  申请人：——

  公开号：US9370522B2

  公开（公告）日：2016-06-21
• Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors
  作者：Lei You、Eun Jeong Cho、John Leavitt、Li-Chung Ma、Gaetano T. Montelione、Eric V. Anslyn、Robert M. Krug、Andrew Ellington、Jon D. Robertus

  DOI：10.1016/j.bmcl.2011.03.042

  日期：2011.5

  A library of quinoxaline derivatives were prepared to target non-structural protein 1 of influenza A (NS1A) as a means to develop anti-influenza drug leads. An in vitro fluorescence polarization assay demonstrated that these compounds disrupted the dsRNA-NS1A interaction to varying extents. Changes of substituent at positions 2, 3 and 6 on the quinoxaline ring led to variance in responses. The most active compounds (35 and 44) had IC50 values in the range of low micromolar concentration without exhibiting significant dsRNA intercalation. Compound 44 was able to inhibit influenza A/Udorn/72 virus growth. (C) 2011 Elsevier Ltd. All rights reserved.